MSA Chief Science Officer to Serve on the PhRMA Foundation Study Review Section.

November 2, 2015

Dr Ken Dretchen , MSA Chief Science Officer, has been invited to sit on the Pharmaceutical Research Manufacturers of America (PhRMA) Foundation study section. Beginning November 2, 2015  Dr. Dretchen will assume his role in the study section where he will  review and advise the Foundation on pre-doctoral, post-doctoral and research starter grant applications. This appointment continues our colleagues continued recognition as a most  important industry leader and as a pharmaceutical scientist.  We at MSA remain in admiration of our friend and colleague and we are proud of the routine recognition he receives from our industry.

MSA News

Internship Experience Reflection – Kaitlyn Wylie

I never thought my first job would be in the biotechnology and pharmacy industry, let alone with such a passionate…

Read More

MesaGreen Pharmaceutical Company Files an Investigational New Animal Drug Application

FREDERICK, MD.  Nov. 10, 2022—MesaGreen Pharmaceutical Company announced today that the company has filed an Investigational New Animal Drug (INAD)…

Read More

Mesa Science Associates Receives Grant to Begin Study of a Treatment for Marfan Syndrome

Mesa Science Associates Inc. (MSA) received a Phase I Small Business Innovative Research Grant (SBIR) from the National Institutes of…

Read More